Magnesium: Forgotten mineral in cardiovascular biology and atherogenesis

New Perspectives in Magnesium Research: Nutrition and Health

Volumn , Issue , 2007, Pages 239-260

  Altura, Burton M ^a   Altura, Bella T ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54049145305     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84628-483-0_19     Document Type: Chapter

References (112)

1. Ross R. Atherosclerosis: A defense mechanism gone awry. Am J Pathol 1993;143: 987-1001
2. Schwartz SM, deBois D, O'Brien ERM. The Intima. Soil for atherosclerosis and restenosis. Circ Res 1995;77:445-465
3. Altura BM, Altura BT. Role of magnesium in the pathogenesis of hypertension updated. In: Laragh JH, Brenner BM, eds. Hypertentension: Pathophysiology, Diagnosis and Management. 2nd ed. New York: Raven Press; 1995:1213-1242
4. Seelig MS. Epidemiologic data on magnesium-deficiency-Associated cardiovascular disease and osteoporosis. In: Rayssiguier Y, Mazur A, Durlach J, eds. Advances in Magnesium Research. Nutrition, and Health. London: John Libbey; 2001:177-190
5. Jeppesen BB. Greenland, a soft water area with a low incidence of ischemic heart death. Magnesium 1987;6:307
6. Seelig MS. Magnesium Deficiency in the Pathogenesis of Disease. New York: Plenum Press; 1980
7. Altura BM, Altura BT. Magnesium and cardiovascular diseases. In: Berthon G, ed. Handbook of Metal-Ligand Interactions in Biological Fluids. Vol. 2. New York: Marcel Dekker; 1995:822-842
8. Altura BM, Altura BT. Magnesium in cardiovascular biology. Sci Am Sci Med 1995;2:28-37
9. Aikawa JK. Magnesium: Its Biological Signifi cance. Boca Raton, FL: CRC Press; 1981
10. Altura BM, Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. I. Clin Magnes 1985;4:226-244
11. Whang R. Magnesium deficiency. Am J Med 1987;82(suppl. 3A):24-29
12. Miyage H, Yasue H, Okumura K, Ogawa H, Goto K, Oshimia S. Effect of magnesium on anginal attack. Circulation 1989;79:597-602
13. Gottlieb SS, Baruch L, Kukin ML, Bernstein JL, Fisher ML, Packer M. Prognostic importance of serum magnesium concentration in patients with congestive heart failure. J Am Coll Cardiol 1990;16:827-831
14. Keller PK, Aronson RS. The role of magnesium in cardiac arrhythmias. Prog Cardiovasc Dis 1990;32:433-488
15. Millane TA, Jennison SH, Mann JM, Holt DW, McKenna WJ, Camm AJ. Myocardial magnesium depletion associated with prolonged hypomagnesemia. J Am Coll Cardiol 1992;20:806-812
16. Sheehan JP. Magnesium deficiency and diabetes mellitus. Magnes Trace Elem 1992;10:215-219
17. Markell MS, Altura BT, Barbour RL, Altura BM. Ionized and total magnesium levels in cyclosporine-Treated renal transplant recipients. Clin Sci 1993;85:315-318
18. Markell MS, Altura BT, Sarn Y, Delany BG, Ifudo O, Friedman EA, Altura BM. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis. ASAIO J 1993;39:M801-M804
19. 2+. Scand J Clin Lab Invest 1994;54(suppl. 217):77-82
20. Amighi J, Sabett S, Schlager O, et al. Low serum magnesium predicts neurological events in patients with advanced atherosclerosis. Stroke 2004;35:22-27
21. Tzankis I, Vividakis K, Tromi A, et al. Intra-And extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res 2004;17:102-108
22. Shirey TL. Monitoring magnesium to guide magnesium therapy for heart surgery. J Anesth 2004;18:118-128
23. Altura BT, Altura BM. A method for distinguishing ionized, complexed and protein-bound Mg in normal and diseased subjects. Scand J Clin Lab Invest 1969;454(suppl. 217):83-87
24. Altura BM. Importance of Mg in physiology and medicine and the need for ion selective electrodes. Scand J Clin Lab Invest 1994;54(suppl. 217):5-10
25. Altura BM, Lewenstein A, eds. Unique magnesium-sensitive electrodes [special issue]. Scand J Clin Lab Invest 1994;54(suppl. 217):1-100
26. Turlapaty PD, Altura BM. Magnesium deficiency produces spasms of coronary arteries. Science 1980;208:198-200
27. Altura BT, Altura BM. Measurement of ionized magnesium in whole blood, plasma and serum with a new ion-selective electrode in healthy and diseased human subjects. Magnes Trace Elem 1991;10:90-98
28. Altura BM, Altura BT. Influence of magnesium on drug-induced contraction and ion content in rabbit aorta. Am J Physiol 1971;220:938-944
29. Altura BM, Altura BT. Magnesium and contraction of arterial smooth muscle. Microvasc Res 1974;7:145-155
30. Altura BM, Altura BT. Magnesium and vascular tone and reactivity. Blood Vessels 1978;25:5-16
31. Altura BM, Altura BT. Magnesium ions and contraction of vascular smooth muscle. Fed Proc 1981;40:2672-2679
32. Altura BM, Altura BT. Magnesium, electrolyte transport and coronary vascular tone. Drugs 1984;28(suppl. 1):120-142
33. 2+ and contractility. Miner Electrolyte Metab 1993;19:323-336
34. 2+-induced endothelialdependent relaxation of blood vessels and blood pressure lowering: Role of NO. Am J Physiol Regul Integr Comp Physiol 2000;278:R628-R639
35. Altura BM, Zhang A, Cheng TPO, et al. Extracellular magnesium regulates nuclear and perinuclear free ionized calcium in cerebral vascular smooth muscle. Alcohol 2001;23:83-90
36. Tonkin A. Atherosclerosis and Heart Disease. London: Martin Dunitz; 2003
37. Herman MP, Sukhova GK, Libby P, et al. Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma. Circulation 2001;104:1899-1904
38. Gallis ZS, Sukhova GK, Lark MN, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-2503
39. Schonbeck D, Libby P. Cytokines and growth regulatory factors. In: Fuster V, Topol EJ, Nabel EG, eds. Atherothrombosis and Coronary Artery Disease. 2nd ed. Philadelphia: Lippincott Williams & Willcins; 2005:547-559
40. Freedman AM, Atrachi AH, Cassidy MM, Weglicki WB. Magnesium deficiencyinduced cardiomyopathy: Protection by vitamin E. Biochem Biophys Res Commun 1990;170:1102-1106
41. Freedman AM, Cassidy MM, Weglicki WB. Captopril protects against myocardial injury by magnesium deficiency. Hypertension 1991;18:142-147
42. Weglicki WB, Phillips TM, Freedman AM, et al. Magnesium deficiency elevates circulating levels of infl ammatory cytokines and endothelin. Mol Cell Biochem 1992;118:105-111
43. Maier JAM, Malpuech-Brugere C, Zimowska W, Rayssiguier Y, Mazur A. Low magnesium promotes endothelial cell dysfunction: Implications for atherosclerosis, infl ammation and thrombosis. Biochim Biophys Acta 2004;689: 13-21
44. Rayssiguier Y, Mazur A. Magnesium and infl ammation: Lessons from animal models. Clin Calcium 2005;15:245-248
45. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991;251:788-791
46. Li H, Cybulsky MI, Gimbrone MA Jr., et al. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 1993;13:197-204
47. Kuranstin-Mills J, Cassidy MM, Stafford RE, Weglicki WB. Marked alterations in circulating infl ammatory cells during cardiomyopathy development in a magnesium-deficient rat model. Br J Nutr 1997;78:845-855
48. Malpuech-Brugere C, Novacki W, Daveau M, et al. Infl ammatory response following acut magnesium deficiency in the rat. Biochim Biophys Acta 2000;1501: 91-98
49. Altura BT, Bust M, Barbour RL, et al. Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci U S A 1990;87:1840-1844
50. Weglicki WB, Kramer JH, Mak IT, et al. Pro-oxidant and pro-infl ammatory neuropeptides in magnesium deficiency. In: Rayssiguier Y, Mazur A, Durlach J, eds. Advances in Magnesium Research: Nutrition and Health. London: John Libbey; 2001:285-289
51. Weaver K. A possible anticoagulant effect of magnesium in preeclampsia. In: Cantin M, Seelig MS, eds. Magnesium in Health and Disease. Holliswood: Spectrum; 1980:833-838
52. Nadler JL, Buchanan T, Natarajan R, et al. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993;21: 1024-1029
53. Gawaz M, Reininger A, Neumann FJ. Platelet function and platelet-leukocyte adhesion in symptomatic coronary heart disease. Effects of intravenous magnesium. Thromb Res 1996;83:341-349
54. Rishi M, Ahmad A, Makheja A, et al. Effects of reduced dietary magnesium on platelet production in hamsters. Lab Invest 1990;63:717-721
55. Stamler JS, Osborne JA, Jaraki O, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993;91:308-318
56. Wrenn RW, Raeber CV, Herman LE, et al. Transforming growth factor-beta. In Vitro Cell Dev Biol Anim 1993;29:73-78
57. Dalton ML, Gadson RF, Robert JR, et al. Homocysteine signal cascade production of phospholipids, activation of protein kinase C and induction of c-fos and c-myb in smooth muscle cells. FASEB J 1997;11:703-711
58. Kang SS, Zhou J, Wong PWK, et al. Intermediate homocystenemia: A thermolabile variant of methylene-Tetrahydrofolate reductase deficiency. Pediatr Res 1988;43: 414-421
59. McKully KS. Vascular pathology of homocystenemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-128
60. Li W, Zheng T, Wang J, et al. Extracellular magnesium regulates effects of vitamin B6, B12 and folate in homocystenemia-induced depletion of intracellular free magnesium ions. Neurosci Lett 1999;274:83-86
61. Guo H, Lee JD, Uzui H, et al. Effects of folic acid and magnesium on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells. Circ J 2006;70:141-146
62. Yang ZW, Zheng T, Zhang A, et al. Mechanism of hydrogen peroxide-induced contraction of rat aorta. Eur J Pharmacol 1998;344:169-181
63. 2+]I in canine cerebral arterial smooth muscle. N S Arch Pharmacol 1999;360:646-653
64. Bharadwaj LA, Prasad K. Mechanism of hydroxyl radical-induced modulation of vascular tone. Free Radic Biol Med 1997;22:381-390
65. Shen JZ, Zheng XF, Kwan CY. Differential contractile actions of reactive oxygen species on rat aorta. Life Sci 2000;66:PL291-PL296
66. Li J, Li W, Liu W, et al. Mechanisms of hydroxyl radical-induced contraction of rat aorta. Eur J Pharmacol 2004;499:171-178
67. Brown MS, Goldstein JL. Receptor-mediated control of cholesterol metabolism. Science 1976;191:150-154
68. Goldstein JL, Ho YK, Basu SK, et al. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979;76:333-337
69. Rosen GM, Freeman BA. Detection of superoxide generated by endothelial cells. Proc Natl Acad Sci U S A 1984;81:7269-7273
70. Daugherty A, Dunn JL, Ratery DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation is expressed in human arteriosclerotic lesions. J Clin Invest 1994;94:437-444
71. Savenkova ML, Mueller DM, Heinecke JW. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J Biol Chem 1994;269:20394-20400
72. Rayssiguier Y, Gueux E, Bussiere L, et al. Dietary magnesium affects susceptibility of lipoproteins and tissues to peroxidation in rats. J Am Coll Nutr 1993;12:133-137
73. Rock E, Astier C, Laub C, et al. Dietary magnesium deficiency in rats enhances free radical production in skeletal muscle. J Nutr 1995;195:1205-1210
74. Malpuech-Brugere C, Kurysko J, Nowacki W, et al. Early morphological and immunological alteration in the spleen during magnesium deficiency in the rat. Magnes Res 1998;11:161-169
75. Bussiere F, Tridon A, Malpuech-Brugere C, et al. Effect of magnesium on the production of reactive oxygen species by neutrophils. Magnes Res 2000;13:81
76. Dickens BF, Weglicki WB, Li S, Mak IT. Magnesium deficiency in-vitro enhances free-radical intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett 1992;311:187-191
77. 2+ in aortic and cerebral vascular smooth muscle cells. Am J Hypertens 2003;16: 701-707
78. Touyz RM, Pu Q, ChenY, et al. Effects of low dietary magnesium intake on development of hypertension in stroke-prone spontaneously hypertensive rats. J Hypertens 2002;11:2141-2143
79. Sherer Y, Bitzur R, Cohen H, et al. Mechanisms of action of the antiatherogenic effect of magnesium: Lessons from a mouse model. Magnes Res 2001;14:173-179
80. Laurant P, Hayoz D, Brunner HR, Berthelot A. Effect of magnesium deficiency on blood pressure and mechanical properties of rat carotid artery. Hypertension 1999;29:1199-1203
81. 2+ effl ux from erythrocytes. Eur J Clin Chem Clin Biochem 1994;32:273-277
82. Wu F, Altura BT, Gao J, et al. Ferrylmyoglobin formation induced by magnesium deficiency in perfused rat heart causes cardiac failure. Biochim Biophys Acta Mol Dis 1994;1225:158-164
83. Giulivi C, Romero FJ, Cardenas E. The interaction of trolox c, a water-soluble vitamin E analog, with ferrylmyoglobin: Reduction of the oxyferryl moiety. Arch Biochem 1992;299:302-312
84. Grisham MB. Myoglobin-catalyzed hydrogen peroxide-dependent arachidonic acid peroxidation. J Free Radic Biol Med 1985;1:227-232
85. Whitburn KD. The interaction of oxymyoglobin with hydrogen peroxide. Arch Biochem Biophys 1987;277:314-321
86. Rice-Evans C, Okunada G, Kahn R. The suppression of iron release from activated myoglobin by physiological electron donors and by desferrioxamine. Free Radic Res Commun 1989;7:45-54
87. Davies MJ, Garlick PB, Slater TF, Hearse DT. In: Rice-Evans C, Dormandy T, eds. Free Radicals, Chemistry, Pathology and Medicine. New York: Richelieu Press;1988:303-319
88. Puppo A, Halliwell B. Formation of hydroxyl radicals in biological systems. Free Radic Res Commun 1988;4:415-422
89. Galaris D, Savarian A, Cadenas E, Hochstein P. Ferrylmyoglobin-catalyzed linoleic acid peroxidation. Arch Biochem Biophys 1990;281:163-169
90. Cohen H, Sherer Y, Shaish A, et al. Atherogenesis inhibition induced by magnesium-chloride fortifi cation of drinking water. Biol Trace Elem Res 2002;90: 251-259
91. Yang ZW, Altura BT, Altura BM. Low extracellular magnesium contraction of arterial smooth muscle: Role of protein kinase C and protein tyrosine phosphorylation. Eur J Pharmacol 1999;378:273-281
92. Yang ZW, Wang J, Altura BT, et al. Extracellular magnesium deficiency induces contraction of arterial smooth muscle: Role of P-I-3 kinases and MAPK signaling pathways. Pflugers Arch 2000;439:240-247
93. 2+]i rises in cerebral arteries. Am J Physiol Heart Circ Physiol 2000;279:H2898-H2407
94. Yang ZW, Wang J, Zheng T, et al. Low extracellular magnesium induces contraction of cerebral arteries: Role of tyrosine and mitogen-Activated protein kinases. Am J Physiol Heart Circ Physiol 2000;279:H185-H194
95. Laurant P, Touyz RM. Physiological and pathophysiological role of magnesium in the cardiovascular system: Implications in hypertension. J Hypertens 2000;18: 1177-1191
96. He Y, Yao G, Savoia C, Touyz RM. Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells. Circ Res 2005;96:207-215
97. Bernardini D, Nasulewicz A, Mazur A, Maier JAM. Magnesium and microvascular endothelial cells: A role in infl ammation and angiogenesis. Front Biosci 2005;10:1177-1182
98. Brautbar N, Altura BM. Hypophosphatemia and hypomagnesemia result in cardiovascular dysfunction. Alcohol Clin Exp Res 1987;11:118-126
99. 2+ in vascular smooth muscle. J Hypertens 1994;12:1024-1029
100. 2+ modulates membrane lipids in vascular smooth muscle: A link to atherogenesis. FEBS Lett 1997;408:191-194
101. Horrocks LA, Sharma M. In: New Comprehensive Biochemistry. Vol. 4. Amsterdam: Elsevier; 1982:51-93
102. Zimmerman GA, Prescott SM, McIntyre TM. Oxidatively fragmented phospholipids as infl ammatory mediators: The dark side of polyunsaturated lipids. J Nutr 1995;125(suppl. 6):1661s-1665s
103. Heery JM, Kozak M, Stafforini DM, et al. Oxidatively modifi ed LDL contains phospholipids with platelet-Activating factor-like activity. J Clin Invest 1995;96: 2322-2330
104. Schissel SL, Tweedie-Hardman J, Rapp JH, et al. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingolyelin of retained low-density lipoprotein. J Clin Invest 1996;98:1455-1464
105. Bolin DJ, Jonas A. Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high-density lipoproteins by decreasing enzyme binding. J Biol Chem 1996;271:19152-19158
106. Arimoto I, Saito H, Kawashima Y, et al. Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions. J Lipid Res 1998;39:143-151
107. Maceyka M, Payne SC, Milstein S, et al. Sphingosine kinase,sphingosine-1- phosphate,and apoptosis. Biochim Biophys Acta 2002;1585:193-201
108. 2+]I in canine cerebral vascular smooth muscle. Am J Physiol Heart Circ Physiol 2002;278:H1421-H1428
109. Bischoff A, Czyborra P, Fetscher C, et al. Sphingosine-1-phosphate and sphingosylphosphoryl-choline constrict renal and mesenteric microvessels in vitro. Br J Pharmacol 2000;130:1871-1877
110. 2+-sensitization of vascular smooth muscle contraction: Possible involvement of rho-kinase. FEBS Lett 2000;482:85-90
111. Altura BM, Gebrewold A, Zheng T, et al. Sphingo-myelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in intact rat brain. Brain Res Bull 2002;58:271-278
112. 2+ modulates membrane sphingolipid and lipid second messenger in vascular smooth muscle cells. FEBS Lett 1998;440:167-171.